Kidney Diseases: all 3,842 studies
Page 33 of 39. Open to participants first (491), then studies with results posted, then the rest; newest registration first within each.
- Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKDCompletedNCT01213992Phase 1
- The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic NephropathyCompletedNCT01213498Phase 2
- An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)CompletedNCT01213485
- Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)Status unknownNCT01211886
- Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney InjuryStatus unknownNCT01210456Phase 3
- Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal DialysisCompletedNCT01209273
- Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast NephropathyCompletedNCT01208818Phase 3
- The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and NephropathyCompletedNCT01208701Phase 2
- Karolinska Cardiorenal Theme-centre and StockholmHeartbankStatus unknownNCT01204645
- Vitamin-D Receptor Activation (VDRA) in Chronic Kidney DiseaseCompletedNCT01204528Phase 2/3
- A Risk Based Approach to Improving Chronic Kidney Disease ManagementCompletedNCT01203813Phase 3
- Diet Intervention in Food Sensitive Patients With IgA NephropathyStatus unknownNCT01203007Not applicable
- Nicotinamide in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01200784Phase 2
- Long-term Study in Chronic Kidney Disease (Extension From Study 14817)CompletedNCT01187628Phase 3
- Effects of Intentional Weight Loss Interventions in Chronic Kidney DiseaseCompletedNCT01180101Phase 2/3
- Lifestyle Modifications and the Progression of Chronic Kidney DiseaseCompletedNCT01179906Not applicable
- Thiazolidinedione (TZD) on the Diabetic Retinopathy and NephropathyStatus unknownNCT01175486Phase 4
- The Impact of Vitamins and Minerals Supplementation on Neuropathy and Nephropathy ComplicationsCompletedNCT01173315Phase 2
- A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.CompletedNCT01173107Phase 4
- The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney DiseaseStatus unknownNCT01165567Phase 4
- To Assess the Accuracy of the eZscan Study in the Screening for Diabetic NephropathyCompletedNCT01163591
- Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus SteroidCompletedNCT01161459Not applicable
- Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial InfarctionCompletedNCT01160627Not applicable
- Uric Acid and Long-term Outcomes in Chronic Kidney DiseaseCompletedNCT01158911
- The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney DiseaseStatus unknownNCT01157260Phase 4
- Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney DiseaseCompletedNCT01156428
- Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney DiseaseStatus unknownNCT01155128Phase 4
- Risk Stratification in End Stage Renal Disease (ESRD) - ISAR StudyStatus unknownNCT01152892
- Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)WithdrawnNCT01151592Phase 4
- Oxidative Stress in Chronic Kidney Disease: Diet and ExerciseCompletedNCT01150851Not applicable
- Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney DiseaseCompletedNCT01150201Phase 4
- A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary HyperparathyroidismCompletedNCT01149291
- A Pilot Study for Pharmacokinetic/Pharmacodynamic (PK/PD) Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease PatientStatus unknownNCT01145274
- Renal Effect of Pentoxyphylline in High Risk Patients Undergoing AngiographyWithdrawnNCT01144091Not applicable
- Role of Donor Genetics and Recipient Genetics in Kidney Transplant OutcomesCompletedNCT01143532
- Polymorphism of Oxidative Stress Genes in the Pathogenesis and Antioxidant Prevention of Contrast Induced NephropathyCompletedNCT01142024Not applicable
- Far Infrared Therapy on AV Fistula Flow, Endothelial Function and Echocardiography in ESRD PatientsStatus unknownNCT01138254Phase 4
- Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney DiseaseCompletedNCT01136564Phase 2
- Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MRCompletedNCT01135316
- Adverse Reactions to MR and CT-examinations (Enhanced and Unenhanced)CompletedNCT01132339
- Comparison of the Protective Effect of Desflurane and Propofol in Patients With Renal TransplantationCompletedNCT01132157Phase 4
- The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes MellitusCompletedNCT01130727Not applicable
- MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5CompletedNCT01121237
- Study of Urinary Angiotensinogen as a Marker to Warn the Deterioration of Renal Function in CKD Patients Early.Status unknownNCT01118494
- Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) StudyCompletedNCT01116947Not applicable
- Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01114594
- Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) PatientsStatus unknownNCT01111422Phase 4
- Determination of in Vivo Ultrafiltration Coefficient (KUF) in Patients With Chronic Kidney Disease (CKD)CompletedNCT01111266Not applicable
- Study in Chronic Kidney Disease (CKD) Not on DialysisCompletedNCT01110629Phase 3
- The Effects of Bindarit in Diabetic NephropathyCompletedNCT01109212Phase 2
- How to Get a Better Dry Weight in End-stage Renal Disease (ESRD) Population for Improving Blood Pressure ControlCompletedNCT01104909Not applicable
- Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney DiseaseStatus unknownNCT01103076Phase 2/3
- Acupuncture for Pain Management of Hemodialysis PatientsTerminatedNCT01102816Not applicable
- Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease (CKD) Patients in SingaporeCompletedNCT01102179
- Vitamin K2 and Vessel Calcification in Chronic Kidney Disease PatientsStatus unknownNCT01101698Phase 4
- Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney DiseaseTerminatedNCT01101269Not applicable
- Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney FunctionTerminatedNCT01100203Phase 3
- Urotensin II in Chronic Kidney Diseases and Kidney TransplantsCompletedNCT01098799
- Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in ChildrenTerminatedNCT01096121Not applicable
- Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney DiseaseCompletedNCT01094769Phase 4
- Periodontal Infection and Systemic Inflammation in Renal PatientsCompletedNCT01094639Not applicable
- Aliskiren in Patients With Idiopathic Membranous NephropathyWithdrawnNCT01093781Not applicable
- Oral Versus Intravenous Hydration to Prevent Contrast Induced NephropathyWithdrawnNCT01093131Phase 4
- Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney DiseaseCompletedNCT01092390Phase 3
- Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) PatientsStatus unknownNCT01091324Phase 3
- Risk Factors for Foot Ulceration in the Chronic Kidney Disease (CKD) PopulationStatus unknownNCT01089829
- Omega-3 Fatty Acid Supplementation in ChildrenCompletedNCT01088776Phase 2
- Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy VolunteersCompletedNCT01087749Phase 1
- Caregivers and Electronic Medication Monitoring in Chronic Kidney DiseaseStatus unknownNCT01087255Phase 1/2
- Screening of Patients Admitted to a Local Hospital With Pocket-sized UltrasoundCompletedNCT01081210
- Small-fiber Neuropathy in Chronic Kidney DiseaseStatus unknownNCT01078857Not applicable
- Placebo Versus SBR759 in Lowering Phosphate in Dialysis PatientsCompletedNCT01069692Phase 3
- Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 DiabetesCompletedNCT01069549
- Involvement of FFA Metabolism and Insulin Resistance in Cardiac DeathCompletedNCT01068080
- Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney DiseaseTerminatedNCT01067963Not applicable
- Behavioral Intervention and Adherence in DialysisCompletedNCT01066949Phase 2
- Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac SurgeryStatus unknownNCT01066351Phase 3
- Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)TerminatedNCT01064895
- Cardiovascular Evaluation Before Renal TransplantationStatus unknownNCT01064674
- Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.CompletedNCT01063556Phase 4
- Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) PatientsStatus unknownNCT01061320Phase 3
- A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT01057407Phase 3
- Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and HyperphosphatemiaCompletedNCT01057108Phase 1
- Effects of PGI2 Analogue Use on the Development of Chronic Allograft NephropathyCompletedNCT01056835Phase 3
- Evaluation of Target Organs Damage in Hypertensive PatientsCompletedNCT01055353
- Managing Chronic Kidney Disease in Eastern North CarolinaCompletedNCT01054066Not applicable
- Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT01053936Phase 2
- Weight Loss Interventions in Obese Patients With Stages 3-4 Chronic Kidney Disease: a Randomised Controlled TrialCompletedNCT01053130Not applicable
- Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing InterventionCompletedNCT01052220Not applicable
- Educating Missouri Patients About Preemptive Living Donor TransplantationCompletedNCT01048437Not applicable
- Repeat Dose Safety and Efficacy Study for Compound to Treat AnemiaCompletedNCT01047397Phase 2
- The Cardiovascular Comorbidity in Children With Chronic Kidney Disease StudyStatus unknownNCT01046448
- Study to Assess Clearances and Bio-compatibility of ELISIO DialyzerCompletedNCT01042327Phase 4
- Consortium for Radiologic Imaging Studies of Polycystic Kidney DiseaseCompletedNCT01039987
- A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza VaccineCompletedNCT01031966Phase 2
- Effects of a Reduction in Kidney Function on Cardiovascular Structure and Function: A Prospective Study of Kidney DonorsCompletedNCT01028703
- Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)CompletedNCT01028287Phase 4
- hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney DiseaseWithdrawnNCT01026363Not applicable
- Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic NephropathyStatus unknownNCT01023373Phase 4
- Contrast Agent-associated Nephrotoxicity in Intensive Care Unit PatientsStatus unknownNCT01017796Early Phase 1